@lenniederde.bsky.social @scievents.bsky.social @infectiousdz.bsky.social #AntimicrobialResistance #ClinicalResearch #DrugDiscovery #Innovation #PublicHealth #Partnership
@lenniederde.bsky.social @scievents.bsky.social @infectiousdz.bsky.social #AntimicrobialResistance #ClinicalResearch #DrugDiscovery #Innovation #PublicHealth #Partnership
At the AMR Conference in Basel, Ecraid announced a new partnership with @incate.bsky.social. Together weβre connecting clinical research & translational innovation to accelerate antimicrobial development & strengthen the pipeline against #AMR. Read how we combine our strengths: bit.ly/INCATE-Ecraid
@ec.europa.eu @scienceinnovation.ec.europa.eu
@erc.europa.eu @vcstx.bsky.social @horizoneu.bsky.social @oxprimarycare.bsky.social @ecrin.bsky.social @lenniederde.bsky.social #horizon2020 #horizoneurope
#respiratoryillness #Flu #ClinicalResearch #pandemicpreparedness
Read more about the EU-funded adaptive platform trials in primary care, and perpetual ongoing studies here:
π¦ ECRAID-Prime Adaptive Platform Trial www.ecraid.eu/ecraid-prime...
π¬ECRAID-Base POS - www.ecraid.eu/ecraid-base/...
Last Friday, @christophercbutler.bsky.social presented at the #RethinkingClinicalTrials webinar (hosted by @dcrinews.bsky.social and @pctcollaboratory.bsky.social). He highlighted pre-pandemic studies & how ECRAID-Prime & ECRAID-Base are strengthening #Europeβs response to future health threats.
@ec.europa.eu @ihieurope.bsky.social @lenniederde.bsky.social
Explore our Perpetual Observational Studies and how their real-world data generated can help advance clinical research and outbreak preparedness. www.ecraid.eu/ecraid-base/...
π«±πΌβπ«²π» We're proud to present the #PrIMAVeRaProject and our #perpetualobervationalstudies at the 7th @amr-accelerator.bsky.social Cross-Project Meeting held in Basel yesterday. We look forward to seeing everyone again at the PrIMAVeRa stakeholder meeting at #ESCMID2026!
@elskesieswerda.bsky.social
@scienceinnovation.ec.europa.eu
@ec.europa.eu @ecdc.europa.eu @eupatientsforum.bsky.social @horizoneu.bsky.social @christophercbutler.bsky.social @lenniederde.bsky.social @vcstx.bsky.social @oxprimarycare.bsky.social
@erc.europa.eu @ema.europa.eu @marcocavaleri.bsky.social
#PandemicPreparedness #DecentralizedTrials #PatientCentricity #ResearchFunding
Read the article here: www.ecraid.eu/news/ecraid-...
@ec.europa.eu @ecdc.europa.eu @eupatientsforum.bsky.social @horizoneu.bsky.social @christophercbutler.bsky.social @lenniederde.bsky.social @vcstx.bsky.social @oxprimarycare.bsky.social
What if, in the next infectious disease outbreak, patients are:
π€ Too sick to travel?
π¦ Unable to visit clinics & traditional research sites?
ποΈ Living in remote or underserved areas?
The #ECRAIDPrime trial demonstrates that research does not need to stop. Trials can come to the patient.
@incate.bsky.social
@lenniederde.bsky.social @idsky.bsky.social @medsky.social @globalamrhub.bsky.social @researchintegrity0.bsky.social @scinews.bsky.social
New collaboration!
Weβre proud to announce that Ecraid has officially partnered with INCATE. We will play a key role in supporting, educating & guiding early-stage translational projects, strengthening their path toward successful development of new treatment modalities to combat #AMR.
See you at #ESCMIDGlobal2026 in Munich! π©πͺ
Find us in the Exhibition Hall (Booth F21), and throughout the scientific programme. Our committed colleagues will present Ecraid-driven science in posters, presentations and talks during the congress.
More details soon!
@escmid.bsky.social
π’ Meet us at the AMR Conference in Basel!
Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you!
π
Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf
@infectiousdz.bsky.social @medsky.social @idsky.bsky.social @researchintegrity.bsky.social @scinews.bsky.social
Ecraidβs second newsletter of the year is out!
Discover the latest updates, studies, publications & upcoming events!
Inside this edition:
πHighlights from the Ecraid Foundation Science Meeting
πThe launch of BE READY NOW
And much more...
ππ½Stay informed, subscribe now: bit.ly/EcraidNewsFe...
@medsky.social @infectiousdz.bsky.social
π’ Meet us at the AMR Conference in Basel!
Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you!
π
Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf
πͺπΊ Our recent CoMeCT project Sustainability Workshop discussed the future development of the projectβs coordination activities and its role in #BEREADY project to strengthen #clinicalresearch readiness for #publichealth emergencies.
Read more on ππ½ www.ecraid.eu/news/coordin...
Lennie Derde speaks about #PandemicPreparedness in @horizoneu.bsky.social Magazine
She explains the importance of a permanent clinical research infrastructure across Europe to tackle emerging #InfectiousDiseases & #AntimicrobialResistance
projects.research-and-innovation.ec.europa.eu/en/horizon-m...
@anrs-mie.bsky.social @rivm-nl.bsky.social @ecrin.bsky.social @sciensano.be
The BE READY NOW European Partnership is live! π
Ecraid is supporting this initiative by building 'ever-warm' research networks & FAIR data protocols, ensuring Europe is ready to respond to threats with unprecedented speed.
π Full details bit.ly/463tpBe
#PandemicPreparedness #ClinicalResearch
Today in #InternationalEducationDay
Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts β from both academia and industry β connect to collaborate and learn.
Explore our Education Page: ecraid.eu/education
π£ The first site has been activated in the PIPELINE-RSV International trial & is now open for recruitment at St George's University Hospitals NHS Foundation Trust in London!
Congratulations to everyone involved in reaching this important milestone!
#RSV #Vaccination #MonoclonalAntibodies #mAbs
@id-journal.bsky.social @medsky.social @infectiousdz.bsky.social @mesamalaria.org @scievents.bsky.social